Treatment success rate: new TB cases in Low income (World Bank)
Low income (World Bank): Treatment success rate: new TB cases was 91 in 2023. ▲ Rising
Latest (2023)
91
Change on year
up 1.1%
Rank
2nd
of 11 groups
All-time high
91
in 2021
All-time low
49
in 1996
Years of data
29
1995–2023
Treatment success rate: new TB cases in Low income (World Bank), 1995–2023
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for treatment success rate: new tb cases in Low income (World Bank) is 91, measured in 2023. That is the highest value across all 29 years on record.
The figure is up 1.1% on the previous year and up 7.1% over ten years.
Over the whole period, treatment success rate: new tb cases in Low income (World Bank) peaked at 91 in 2021 and was at its lowest, 49, in 1996.
The long-run direction has been consistently rising across the 29 years of available data.
Treatment success rate: new TB cases in Low income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 1995 | 59 | — |
| 1996 | 49 | -16.9% |
| 1997 | 61 | +24.5% |
| 1998 | 68 | +11.5% |
| 1999 | 71 | +4.4% |
| 2000 | 74 | +4.2% |
| 2001 | 74 | +0.0% |
| 2002 | 75 | +1.4% |
| 2003 | 79 | +5.3% |
| 2004 | 80 | +1.3% |
| 2005 | 81 | +1.2% |
| 2006 | 75 | -7.4% |
| 2007 | 82 | +9.3% |
| 2008 | 83 | +1.2% |
| 2009 | 82 | -1.2% |
| 2010 | 83 | +1.2% |
| 2011 | 84 | +1.2% |
| 2012 | 85 | +1.2% |
| 2013 | 85 | +0.0% |
| 2014 | 85 | +0.0% |
| 2015 | 86 | +1.2% |
| 2016 | 86 | +0.0% |
| 2017 | 86 | +0.0% |
| 2018 | 87 | +1.2% |
| 2019 | 88 | +1.1% |
| 2020 | 90 | +2.3% |
| 2021 | 91 | +1.1% |
| 2022 | 90 | -1.1% |
| 2023 | 91 | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 61.6 | 49 | 71 | 5 |
| 2000s | 78.5 | 74 | 83 | 10 |
| 2010s | 85.5 | 83 | 88 | 10 |
| 2020s | 90.5 | 90 | 91 | 4 |
Countries ranked near Low income (World Bank)
- 1 Saint Kitts and Nevis 100 compare
- 1 Barbados 100 compare
- 1 Tonga 100 compare
- 1 Cook Islands 100 compare
- 1 Andorra 100 compare
- 1 Samoa 100 compare
- 1 Palestine, State of 100 compare
More health data for Low income (World Bank)
- Pertussis - number of reported cases, gaps filled 16,008 (2025)
- Total tetanus - number of reported cases, gaps filled 5,130 (2025)
- Diphtheria - number of reported cases, gaps filled 7,814 (2025)
- Measles - number of reported cases, gaps filled 197,977 (2025)
- Measles - number of reported cases, annual growth rate 6.99 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate 289.49 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate -48.45 % change on previous year (2025)
- Diphtheria - number of reported cases 7,814 (2025)
- Total tetanus - number of reported cases 5,130 (2025)
- Pertussis - number of reported cases 16,008 (2025)
Frequently asked questions
- What is treatment success rate: new tb cases in Low income (World Bank)?
- Treatment success rate: new tb cases in Low income (World Bank) was 91 in 2023, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate: new tb cases recorded in Low income (World Bank)?
- The highest recorded value was 91 in 2021.
- What is the lowest treatment success rate: new tb cases recorded in Low income (World Bank)?
- The lowest recorded value was 49 in 1996.
- How does Low income (World Bank) rank for treatment success rate: new tb cases?
- Low income (World Bank) ranks 2nd out of 11 groups with data for 2023.
- Is treatment success rate: new tb cases rising or falling in Low income (World Bank)?
- Over the last ten years it is up 7.1%. The long-run trend across the full record is rising.
- Where does this Low income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate: new TB cases. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 29 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).